Skip to main content
Top
Published in: Clinical Rheumatology 11/2007

01-11-2007 | Brief Report

Chronic myositis with cardiomyopathy and respiratory failure associated with mild form of organ-specific autoimmune diseases

Authors: K. Tanaka, A. Sato, K. Kasuga, M. Kanazawa, K. Yanagawa, M. Umeda, M. Tada, M. Tanaka, M. Nishizawa

Published in: Clinical Rheumatology | Issue 11/2007

Login to get access

Abstract

We report the four patients with chronic myositis characterized by a very slow progression with cardiomyopathy and frequently with marked respiratory muscle weakness associated with other organ-specific autoimmune diseases such as primary biliary cirrhosis. The histopathology of the muscle showed many degenerative and regenerative fibers, but inflammatory-cell infiltration were minimal. The patients showed favorable response to high-dose corticosteroid treatment. Because of these clinical features, these patients are sometimes misdiagnosed as muscular dystrophy and not treated properly. It is important to distinguish this type of treatable myositis.
Literature
1.
go back to reference Arahata K, Engel AG (1988) Monoclonal antibody analysis of mononuclear cells in myopathies: IV. Cell-mediated cytotoxicity and muscle fiber necrosis. Ann Neurol 23:168–173PubMedCrossRef Arahata K, Engel AG (1988) Monoclonal antibody analysis of mononuclear cells in myopathies: IV. Cell-mediated cytotoxicity and muscle fiber necrosis. Ann Neurol 23:168–173PubMedCrossRef
2.
go back to reference Dalakas MC (2004) Inflammatory disorders of muscle: progress in polymyositis, dermatomyositis and inclusion body myositis. Curr Opin Neurol 17:561–567PubMedCrossRef Dalakas MC (2004) Inflammatory disorders of muscle: progress in polymyositis, dermatomyositis and inclusion body myositis. Curr Opin Neurol 17:561–567PubMedCrossRef
3.
go back to reference Griggs RC, Askanas V, DiMauro S, Engel A, Karpati G, Mendell JR, Rowland LP (1995) Inclusion body myositis and myopathies. Ann Neurol 38:705–713PubMedCrossRef Griggs RC, Askanas V, DiMauro S, Engel A, Karpati G, Mendell JR, Rowland LP (1995) Inclusion body myositis and myopathies. Ann Neurol 38:705–713PubMedCrossRef
4.
go back to reference Matsui K, Aizawa Y, Inoue K, Yaguchi H, Toda G (2000) Polymyositis with marked paravertebral muscle atrophy in patients with primary biliary cirrhosis. Clin Neurol 40:694–700 Matsui K, Aizawa Y, Inoue K, Yaguchi H, Toda G (2000) Polymyositis with marked paravertebral muscle atrophy in patients with primary biliary cirrhosis. Clin Neurol 40:694–700
5.
go back to reference Migueletto BC, Neto AE, Domingues EZ, Neves de Castro PP, Stocker H, Marie SK, Meireles LP, Arai MH (1999) Primary biliary cirrhosis and myopathy: An uncommon association. Rev Hosp Clin Fac Med Sao Paulo 54:165–168PubMed Migueletto BC, Neto AE, Domingues EZ, Neves de Castro PP, Stocker H, Marie SK, Meireles LP, Arai MH (1999) Primary biliary cirrhosis and myopathy: An uncommon association. Rev Hosp Clin Fac Med Sao Paulo 54:165–168PubMed
6.
go back to reference Varga J, Heiman-Patterson T, Munoz S, Love LA (1993) Myopathy with mitochondrial alterations in patients with primary biliary cirrhosis and antimitochondrial antibodies. Arthritis Rheum 36:1468–1475PubMedCrossRef Varga J, Heiman-Patterson T, Munoz S, Love LA (1993) Myopathy with mitochondrial alterations in patients with primary biliary cirrhosis and antimitochondrial antibodies. Arthritis Rheum 36:1468–1475PubMedCrossRef
7.
go back to reference Abraham S, Begum S, Isenberg D (2004) Hepatic manifestations of autoimmune rheumatic diseases. Ann Rheum Dis 63:123–129PubMedCrossRef Abraham S, Begum S, Isenberg D (2004) Hepatic manifestations of autoimmune rheumatic diseases. Ann Rheum Dis 63:123–129PubMedCrossRef
Metadata
Title
Chronic myositis with cardiomyopathy and respiratory failure associated with mild form of organ-specific autoimmune diseases
Authors
K. Tanaka
A. Sato
K. Kasuga
M. Kanazawa
K. Yanagawa
M. Umeda
M. Tada
M. Tanaka
M. Nishizawa
Publication date
01-11-2007
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 11/2007
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-007-0698-7

Other articles of this Issue 11/2007

Clinical Rheumatology 11/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine